Merz Pharmaceuticals GmbH clinical trials
A subsidiary of Merz Pharma
The registry lists 61 studies whose lead sponsor is Merz Pharmaceuticals GmbH. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 20, 2026.
Registry sponsor names on this page
- Merz Pharmaceuticals GmbH61 studies
Something wrong with this grouping? Tell us on the Merz Pharma page.
Studies
Recruiting first, then most recently updated. Showing 50 of 61. List all 61 → · All Merz Pharma studies →
- Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain InjuryActive, not recruitingNCT03992404Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- A Study to Investigate the Efficacy and Safety of NT 201 (Botulinum Toxin) Compared With Placebo for the Treatment of Adult Participants With Essential Tremor in the ArmCompletedNCT04766723Phase 2
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- A Study to Evaluate the Distribution of Botulinum Neurotoxin Type A Administered as Intradermal Injections, Comparing Different Doses, Concentrations, and Delivery MethodsCompletedNCT05585398Phase 1
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Blepharospasm Patient Survey for Patients With BlepharospasmCompletedNCT01686061
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia FlexCompletedNCT01486264Phase 4
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Local Study of Akatinol Memantine in VaD in RussiaCompletedNCT03986424Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual DisabilityCompletedNCT02270736Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral PalsyCompletedNCT02002884Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Leg(s) in Cerebral PalsyCompletedNCT01893411Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Safety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown LinesCompletedNCT00512135Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Botulinum Toxin A to Treat Arm TremorCompletedNCT02207946Phase 2
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Post-Market Clinical Follow-up Performance and Safety Study of Etermis 3 and 4 in the FaceCompletedNCT04210258
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Evaluation of the Sensitivity of Merz Lips Fullness Assessment Scale Following Etermis 4® Treatment for Lips Volume AugmentationCompletedNCT03256942Not applicable
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological ConditionsCompletedNCT02091739Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the EyelidCompletedNCT01896895Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral PalsyCompletedNCT01905683Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and ArmCompletedNCT01603459Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral PalsyCompletedNCT02188277Phase 2
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a StrokeCompletedNCT01392300Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a StrokeCompletedNCT01464307Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective TinnitusCompletedNCT00739635Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Effectiveness and Safety Study of Overnight Intensive Patch in ScarsCompletedNCT01910896Not applicable
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Effect of NT 201 (Botulinum Neurotoxin Type A Free of Complexing Proteins) on Sleep-related Breathing DisordersWithdrawnNCT00773591Phase 2
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Contractubex Treatment in Scars After Abdominal Caesarean SectionCompletedNCT01112371Phase 4
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma PatientsCompletedNCT01714960Phase 1
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair LossCompletedNCT01900041Phase 2
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Investigation of Memantine in the Treatment of Memory, Concentration or Attention ProblemsCompletedNCT01261741Phase 2
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical DystoniaCompletedNCT00407030Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Dose Finding Study for a Botulinum Toxin Type A Injection to Treat Habitual SnoringTerminatedNCT01515371Phase 2
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Cervical DystoniaCompletedNCT00541905Phase 4
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of BlepharospasmCompletedNCT00406367Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines No. 2CompletedNCT00770029Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Memantine and Validation of a New Alzheimer's Disease ScaleCompletedNCT00804271Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective TinnitusTerminatedNCT00827008Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective TinnitusCompletedNCT00955799Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown LinesCompletedNCT00694148Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Efficacy and Safety of NT 201 in the Treatment of Lateral Periorbital WrinklesCompletedNCT00541723Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown LinesCompletedNCT00777803Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Blepharospasm Short IntervalTerminatedNCT00507637Phase 2
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Memantine - Communication StudyCompletedNCT00624026Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown LinesCompletedNCT00430963Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown LinesCompletedNCT00770211Phase 3
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Memantine and Antipsychotics UseTerminatedNCT00649220Phase 4
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown LinesCompletedNCT00430586Phase 2
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Non-inferiority of Belotero® Basic Versus Juvéderm® Ultra 3CompletedNCT01305187Phase 4
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Study to Evaluate the Effects of Neramexane on the Pharmacokinetics of a Combined Drospirenone/Ethinyl Estradiol Oral Contraceptive in Healthy Female SubjectsCompletedNCT00915174Phase 1
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Evaluation of Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of Neramexane Mesylate in Healthy Japanese SubjectsCompletedNCT00983099Phase 1
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Neramexane for TinnitusCompletedNCT00405886Phase 2
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Evaluation of Dose-Dependent Repeated-Dose Neramexane Effects on Cardiac Repolarisation (QT/QTc Interval Duration): Electrocardiogram (ECG) Study in Healthy Adult SubjectsCompletedNCT00978614Phase 1
Sponsor listed in the registry: Merz Pharmaceuticals GmbH
- Study Analyzing the Effect of Rifampicin Administration on the Pharmacokinetics of Neramexane MesylateCompletedNCT00955760Phase 1
Sponsor listed in the registry: Merz Pharmaceuticals GmbH